Editor Profile

Robert Dreicer, MD, MS, FACP, FASCO

Associate Editor

About the NEJM Watch Oncology and Hematology Board

Dr. Dreicer is Head of the Section of Medical Oncology and Deputy Director of the University of Virginia Cancer Center. He received his Medical Degree and Master of Science from the University of Texas, Houston. He completed internal medicine residency training at Indiana University and a medical oncology fellowship at the University of Wisconsin. He is a fellow of the American College of Physicians and the American Society of Clinical Oncology. Dr. Dreicer is an academic clinical investigator in the area of urologic oncology. He is Co-Chair of the NCI GU Steering Committee and member of the American Board of Internal Medicine, Medical Oncology Test Writing Committee. Dr. Dreicer has been writing for NEJM Journal Watch Oncology and Hematology since 2006.


Consultant / Advisory board

Medivation; Genentech/Roche; AstraZeneca; Bristol-Myers Squibb; Eisai; Exelixis; Asana

Editorial boards

Clinical Genitourinary Cancer; Current Urology Reports

Leadership positions in professional societies

National Cancer Institute (Co-Chair, GU Oncology Steering Committee); Bladder Cancer Advocacy Network (Member, Scientific Advisory Board)

Summaries by Robert Dreicer